Published in J Neurosurg on November 01, 1991
The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med (2009) 3.05
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95
Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88
Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol (2012) 1.79
Biology of vascular malformations of the brain. Stroke (2009) 1.70
KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci U S A (2002) 1.57
Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet (2006) 1.52
Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A (1995) 1.43
Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry (1999) 1.29
Giant cavernous hemangiomas: report of three cases. Neurosurg Rev (2006) 1.28
Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc Natl Acad Sci U S A (2011) 1.23
STRIPAK complexes: structure, biological function, and involvement in human diseases. Int J Biochem Cell Biol (2013) 1.13
Endogenous endothelial cell signaling systems maintain vascular stability. Angiogenesis (2009) 1.12
Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models. Neurosurgery (2008) 1.12
Rates and predictors of seizure freedom in resective epilepsy surgery: an update. Neurosurg Rev (2014) 1.02
Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3. BMC Biochem (2011) 0.99
Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review. Neurosurg Focus (2010) 0.98
Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling. Biol Chem (2013) 0.94
Immune response in human cerebral cavernous malformations. Stroke (2009) 0.94
Cystic cavernous angiomas. Neurosurg Rev (2010) 0.93
Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype. FEBS J (2010) 0.92
Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol (2014) 0.91
Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions. Neurosurgery (2008) 0.91
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum Mol Genet (2014) 0.91
Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate. PLoS One (2010) 0.91
Familial cavernous malformations in a large French kindred: mapping of the gene to the CCM1 locus on chromosome 7q. J Neurol Neurosurg Psychiatry (1997) 0.91
Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. Cerebrovasc Dis (2013) 0.90
Cavernous malformations of the central nervous system (CNS) in children: clinico-radiological features and management outcomes of 36 cases. Childs Nerv Syst (2014) 0.89
Cavernous malformation of the optic chiasm : case report. J Korean Neurosurg Soc (2008) 0.89
Lack of CCM1 induces hypersprouting and impairs response to flow. Hum Mol Genet (2014) 0.88
Chronic encapsulated intracerebral hematoma--a well-defined disease. Report on two cases and review of the literature. Neurosurg Rev (1997) 0.87
Giant cavernous malformation : a case report and review of the literature. J Korean Neurosurg Soc (2008) 0.87
Intramedullary cavernoma presenting with hematomyelia: report of two girls. Childs Nerv Syst (2009) 0.85
Intramedullary spinal cord cavernous angioma in children: case report and literature review. Childs Nerv Syst (2007) 0.85
Cavernous malformations after cerebral irradiation during childhood: report of nine cases. Childs Nerv Syst (2005) 0.84
Susceptibility-weighted imaging at 7 T: Improved diagnosis of cerebral cavernous malformations and associated developmental venous anomalies. Neuroimage Clin (2012) 0.82
Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab (2015) 0.82
Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations. Transl Stroke Res (2013) 0.80
Cavernous angioma of the VIIIth cranial nerve. A case report. Neurosurg Rev (1998) 0.80
Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients. Childs Nerv Syst (2006) 0.80
Radiological features of childhood giant cavernous malformations. Neuroradiology (2010) 0.79
Cerebellar cavernous malformations with and without associated developmental venous anomalies. BMC Neurol (2013) 0.79
Inherited cavernous malformations of the central nervous system: clinical and genetic features in 19 Swiss families. Neurosurg Rev (2009) 0.79
Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations. AJNR Am J Neuroradiol (2016) 0.79
Surgical management of brain-stem cavernomas. Neurosurg Rev (1997) 0.77
Congenital cavernous angioma exhibits a progressive decrease in size after birth. Childs Nerv Syst (2003) 0.77
The benefit of neuronavigation for the treatment of patients with intracerebral cavernous malformations. Neurosurg Rev (2007) 0.77
Surgical management of cavernous malformations presenting with drug-resistant epilepsy. Front Neurol (2012) 0.76
Intraventricular cavernous malformation radiologically mimicking meningioma. J Korean Neurosurg Soc (2008) 0.76
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. Case Rep Neurol Med (2013) 0.76
Rho kinase as a target for cerebral vascular disorders. Future Med Chem (2015) 0.76
Systems biology and proteomic analysis of cerebral cavernous malformation. Expert Rev Proteomics (2014) 0.76
Management of intracranial cavernous malformation in pediatric patients. Childs Nerv Syst (2007) 0.76
Management of cerebral cavernous malformations: from diagnosis to treatment. ScientificWorldJournal (2015) 0.76
Familial cerebral cavernous malformation: report of a further Italian family. Neurol Sci (2009) 0.76
Neonatal cavernous angioma located in the basal ganglia with profuse intraoperative bleeding. Childs Nerv Syst (2006) 0.76
Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging. JAMA Neurol (2017) 0.76
Surgical management of cavernous malformation of the optic nerve with canalicular extension. Surg Neurol Int (2014) 0.75
Treatment of Nystagmus in Brainstem Cavernous Malformation with Botulinum Toxin. Cureus (2016) 0.75
Unusual Presentation of Cerebral Cavernous Malformation. J Cerebrovasc Endovasc Neurosurg (2015) 0.75
Endoscopic approaches to brainstem cavernous malformations: Case series and review of the literature. Surg Neurol Int (2015) 0.75
Radiosurgery for symptomatic cavernous malformations: A multi-institutional retrospective study in Japan. Surg Neurol Int (2015) 0.75
Intracranial haemorrhage in pregnancy. Obstet Med (2009) 0.75
Role of cytoskeletal proteins in cerebral cavernous malformation signaling pathways: a proteomic analysis. Mol Biosyst (2014) 0.75
Vascular malformations of central nervous system: A series from tertiary care hospital in South India. J Neurosci Rural Pract (2016) 0.75
Increased NRG1-ErbB4 signaling in human symptomatic epilepsy. Sci Rep (2017) 0.75
Intracranial haemangioma: clinical features and radiological appearances. Ulster Med J (1999) 0.75
Simultaneous and sequential hemorrhage of multiple cerebral cavernous malformations: a case report. J Med Case Rep (2016) 0.75
The value of T(2) (*)-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families. Exp Ther Med (2012) 0.75
Pediatric cerebral cavernous malformations: Genetics, pathogenesis, and management. Surg Neurol Int (2016) 0.75
KRIT1 mutations in three Japanese pedigrees with hereditary cavernous malformation. Hum Genome Var (2016) 0.75
Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies. Neurology (2016) 0.75
Optic chiasmal cavernous angioma: A rare suprasellar vascular malformation. Surg Neurol Int (2016) 0.75
Lumbar extradural dumbbell cavernous hemangioma: A rare lesion. J Neurosci Rural Pract (2013) 0.75
Microsurgical treatment and outcome of pediatric supratentorial cerebral cavernous malformation. J Korean Neurosurg Soc (2014) 0.75
FAM222B Is Not a Likely Novel Candidate Gene for Cerebral Cavernous Malformations. Mol Syndromol (2016) 0.75
Hemichorea reversible after operation in a boy with cavernous angioma in the head of the caudate nucleus. J Neurol Neurosurg Psychiatry (1994) 0.75
Cavernous malformation of the optic chiasm: Neuro-endoscopic removal. Asian J Neurosurg (2016) 0.75
Genetically diagnosed Birt-Hogg-Dubé syndrome and familial cerebral cavernous malformations in the same individual: a case report. Fam Cancer (2016) 0.75
Systemic Expression of Vascular Endothelial Growth Factor in Patients with Cerebral Cavernous Malformation Treated by Stereotactic Radiosurgery. J Korean Neurosurg Soc (2016) 0.75
Concepts and hypothesis: integrin cytoplasmic domain-associated protein-1 (ICAP-1) as a potential player in cerebral cavernous malformation. J Neurol (2012) 0.75
Endoscopic management of a cavernous malformation on the floor of third ventricle and aqueduct of Sylvius: Technical case report and review of the literature. Surg Neurol Int (2017) 0.75
Successful excision of hemorrhagic cavernous angioma in a patient with severe factor VII deficiency: perioperative treatment with factor VII concentrate. Neurosurg Rev (1997) 0.75
Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor. Childs Nerv Syst (2017) 0.75
Lethal recurrent hemorrhages of a brainstem cavernoma. Neurosurg Rev (2007) 0.75
Clinical Management of Cavernous Malformations. Curr Cardiol Rep (2017) 0.75
Pediatric cerebellar giant cavernous malformation: case report and review of literature. Childs Nerv Syst (2017) 0.75
Spontaneous bleeding into a suprasellar cavernous angioma of a neonate: case report and literature review. Childs Nerv Syst (2010) 0.75
Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg (1990) 2.97
Endovascular therapeutic approach to peripheral aneurysms of the superior cerebellar artery. AJNR Am J Neuroradiol (1996) 2.55
New fluorescence assay for the quantitation of fungi. J Clin Microbiol (1989) 2.26
Preparation and characterization of antibodies specific for the 2,4,6-trinitrophenyl group. Biochemistry (1966) 2.20
Campylobacter enteritis from untreated water in the Rocky Mountains. Ann Intern Med (1983) 2.17
Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet (1998) 2.16
Kawasaki-like syndromes associated with human immunodeficiency virus infection. Clin Infect Dis (2001) 2.16
Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke (2001) 1.97
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke (1987) 1.96
A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis (1997) 1.90
Recovery of binding activity in reconstituted mouse myeloma proteins. Biochemistry (1971) 1.75
Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology (1994) 1.70
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke (1987) 1.66
Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery (2000) 1.65
Impact of Guglielmi detachable coils on outcomes of patients with intracranial aneurysms treated by a multidisciplinary team at a single institution. J Neurosurg (2000) 1.62
Meningeal carcinomatosis. Clinical manifestations. Arch Neurol (1974) 1.54
Spontaneous angiographic obliteration of cerebral arteriovenous malformations. Neurosurgery (1999) 1.54
Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol (1994) 1.52
Colloid cysts of the third ventricle. J Neurosurg (1974) 1.52
Postoperative hemorrhage: a survey of 4992 intracranial procedures. Neurosurgery (1988) 1.50
Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli. J Biol Chem (1993) 1.49
Patch angioplasty in carotid endarterectomy. Advantages, concerns, and controversies. Stroke (1989) 1.47
Specificity of the immune response to the 2,4-dinitrophenyl and 2,4,6-trinitrophenyl groups. Ligand binding and fluorescence properties of cross-reacting antibodies. J Exp Med (1969) 1.44
Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A (1995) 1.43
Modulation of the macrophage oxidative burst by Histoplasma capsulatum. J Immunol (1987) 1.42
Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery (1995) 1.41
Reversal of a dense, persistent, holohemispheric neurological deficit after an endarterectomy of the carotid artery: case report. Neurosurgery (1991) 1.40
MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol (1998) 1.40
Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery (1996) 1.39
The effect of subarachnoid hemorrhage on blood and CSF atrial natriuretic factor. J Neurosurg (1989) 1.38
Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol (1992) 1.29
Clinical manifestations of aqueductal stenosis in adults. J Neurosurg (1975) 1.29
The MetaFam Server: a comprehensive protein family resource. Nucleic Acids Res (2001) 1.29
A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med (1996) 1.28
Degeneracy in the secondary immune response: stimulation of antibody formation by cross-reacting antigens. Isr J Med Sci (1969) 1.27
Prediction of cognitive change as a function of preoperative ability status among temporal lobectomy patients seen at 6-month follow-up. Neurology (1991) 1.26
Digital subtraction angiography of the carotid arteries: a comparative study in 100 patients. Radiology (1981) 1.25
In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester. Antimicrob Agents Chemother (1985) 1.24
Augmentation of murine immune responses by amphotericin B. Cell Immunol (1977) 1.23
The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis (1996) 1.18
Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2000) 1.17
Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke (1987) 1.16
A method for the derivation and continuous propagation of cloned murine bone marrow macrophages. J Immunol Methods (1983) 1.15
A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery (1999) 1.15
Evidence for tryptophan in the active sites of antibodies to polynitrobenzenes. Biochemistry (1967) 1.14
Infratentorial arachnoid cysts. J Neurosurg (1973) 1.14
Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery (1993) 1.14
Intracranial internal carotid artery stenosis: longterm prognosis. Stroke (1983) 1.14
Extent of resection in temporal lobectomy for epilepsy. II. Memory changes and neurologic complications. Epilepsia (1990) 1.11
Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities. Infect Immun (1989) 1.10
Immune response deficiency of BSVS mice. II. Generalized deficiency to thymus-dependent antigens. Eur J Immunol (1979) 1.10
Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery (1993) 1.09
Giant fusiform aneurysm of the cerebral arteries. Stroke (1981) 1.07
Immunopotentiating effects of amphotericin B. I. Enhanced contact sensitivity in mice. J Immunol (1979) 1.07
Symptomatic Chiari malformation in adults: a new classification based on magnetic resonance imaging with clinical and prognostic significance. Neurosurgery (1991) 1.06
Microcirculatory obstruction in focal cerebral ischemia. Relationship to neuronal alterations. Mayo Clin Proc (1975) 1.05
Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery (1996) 1.04
Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery (2001) 1.03
Functional anatomy of the human supplementary sensorimotor area: results of extraoperative electrical stimulation. Electroencephalogr Clin Neurophysiol (1994) 1.03
Properties of the active sites of antibodies specific for folic acid. Biochemistry (1970) 1.02
Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke (2000) 1.02
Affinity and heterogeneity of antibodies induced by epsilon-2,4-dinitrophenylinsulin. Biochemistry (1969) 1.02
Pituitary apoplexy: a complication of cardiac surgery. Ann Thorac Surg (1986) 1.01
Basilar and distal vertebral artery stenosis: long-term follow-up. Stroke (1986) 1.01
Digital subtraction angiography in cerebrovascular disease. Stroke (1982) 1.01
The extracranial-intracranial bypass study. Surg Neurol (1986) 1.01
Brain hemorrhage from intracranial tumor. Stroke (1979) 1.01
Comparison of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus in children. Mayo Clin Proc (1972) 1.00
Thoracic spinal canal stenosis. J Neurosurg (1987) 0.99
Relationship between the antibiotic and immunoadjuvant effects of amphotericin B methyl ester. Immunochemistry (1978) 0.99
Intracarotid amobarbital procedure as a predictor of material-specific memory change after anterior temporal lobectomy. Epilepsia (1995) 0.99
Primary pulmonary botryomycosis: case report and review. Clin Infect Dis (1998) 0.98
Cerebellar hemorrhage in adults. Diagnosis by computerized tomography. J Neurosurg (1978) 0.98
Misdiagnosis of symptomatic cerebral aneurysm. Prevalence and correlation with outcome at four institutions. Stroke (1996) 0.96
Different mechanisms for the modulation of TL antigens on murine lymphoid cells. J Immunol (1976) 0.96
Growth inhibition of Cryptococcus neoformans by cloned cultured murine macrophages. Cell Immunol (1984) 0.96
Effect of ketones on metabolism of FFA by dog myocardium and skeletal muscle in vivo. Am J Physiol (1970) 0.96
Retrolabyrinthine transtentorial approach to lesions of the anterior cerebellopontine angle. Am J Otol (1992) 0.95
Effect of albumin concentration on function of isolated perfused rat kidney. Am J Physiol (1974) 0.95
Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery (1996) 0.94
Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). AJNR Am J Neuroradiol (1996) 0.93
Immunopotentiating effects of amphotericin B. II. Enhanced in vitro proliferative responses of murine lymphocytes. J Immunol (1979) 0.93
Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia (1994) 0.93
Giant and multiple aneurysms of the distal posterior inferior cerebellar artery. Neurosurgery (1988) 0.93
The PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activity. Infect Immun (1994) 0.92
Neuronal alterations in developing cortical infarction. An experimental study in monkeys. J Neurosurg (1974) 0.92
Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg (1990) 0.92
Short vein grafts for cerebral revascularization. J Neurosurg (1983) 0.91
Altered cerebral autoregulation and CO2 reactivity after aneurysmal subarachnoid hemorrhage. Neurosurgery (1988) 0.91
De novo development of a cavernous malformation of the spinal cord following spinal axis radiation. Case report. J Neurosurg (1999) 0.90
Bronchogenic carcinoma with a brain metastasis: a continuing challenge. Ann Thorac Surg (1979) 0.90
Treatment of acute focal cerebral ischemia with propranolol. Stroke (1982) 0.90
CO2 reactivity and heterogeneity of cerebral blood flow in ischemic, border zone, and normal cortex. Am J Physiol (1989) 0.90
Physical and chemical differences between rabbit antibodies to the 2,4-dinitrophenyl and the 2,4,6-trinitrophenyl groups. Biochemistry (1968) 0.90
Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: preliminary observations and working hypothesis. Neurol Res (1995) 0.90
The binding reactions of antibodies specific for the 2,6-dinitrophenyl group. J Immunol (1969) 0.90
Comparative localization of auditory comprehension by using functional magnetic resonance imaging and cortical stimulation. J Neurosurg (1999) 0.89